WHO recommends lifestyle changes over GLP-1 drugs for child obesity

The World Health Organization endorsed diet, exercise, and counseling over weight-loss drugs for younger children, citing safety and long-term effectiveness concerns. GLP-1 drugs may be considered for adolescents aged 10 to 19 after supervised interventions fail.

Why it matters. Children and adolescents under 10 are advised against obesity medication, focusing instead on lifestyle changes that could affect public health and healthcare policies globally.